NCT00063401 2010-04-08Phase II Study in Patients With Epidermal Growth Factor Receptor (EGFR) + Advanced Stage Ovarian, Primary Peritoneal and Fallopian Tube CancerEli Lilly and CompanyPhase 2 Completed39 enrolled